
2006December 5, 2006Maxygen Announces Grant of Biofuels License to Codexis, Inc. November 7, 2006Maxygen's Next-Generation Interferon Alpha Enters Phase Ia Clinical Trial November 1, 2006Maxygen to Present at the Rodman & Renshaw 8th Annual Healthcare Conference and the ThinkEquity ThinkTank Summit October 30, 2006Maxygen Reports Third Quarter 2006 Financial Results October 27, 2006Maxygen to Receive $17.8 Million From Acquisition of Avidia by Amgen October 24, 2006Maxygen to Host Third Quarter 2006 Financial Results Conference Call on October 30, 2006 September 20, 2006Maxygen to Present at the UBS 2006 Global Life Sciences Conference September 5, 2006Maxygen Initiates Phase I Clinical Trial for Maxy-G34 July 31, 2006Maxygen Reports Second Quarter 2006 Financial Results July 18, 2006Maxygen to Host Second Quarter 2006 Financial Results Conference Call on July 31, 2006 June 7, 2006Maxygen to Present at the Goldman Sachs Healthcare Conference May 9, 2006Maxygen Achieves Milestone in Alliance with Roche for Factor VIIa Therapeutics April 25, 2006Maxygen Reports First Quarter 2006 Financial Results March 1, 2006Maxygen to Present at the Cowen & Co. 26th Annual Health Care Conference and the Lehman Brothers Ninth Annual Global Healthcare Conference February 8, 2006Maxygen to Present at the BIO CEO & Investor Conference February 8, 2006Maxygen Reports Fourth Quarter and Year End 2005 Financial Results January 30, 2006Maxygen to Host Fourth Quarter and Year End 2005 Financial Results Conference Call on February 8, 2006 January 5, 2006Maxygen to Present at the JP Morgan 24th Annual Healthcare Conference
Return to News
|